Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H14N2O2 |
Molecular Weight | 206.2411 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(=O)NC(N)=O)C1=CC=CC=C1
InChI
InChIKey=AJOQSQHYDOFIOX-UHFFFAOYSA-N
InChI=1S/C11H14N2O2/c1-2-9(10(14)13-11(12)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H3,12,13,14,15)
Molecular Formula | C11H14N2O2 |
Molecular Weight | 206.2411 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionCurator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/529017
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/529017
Pheneturide ((brand names Benuride, Deturid, Pheneturid, Septotence, Trinuride), a decarboxylation product of phenobarbital, has been shown to be an effective drug against seizures, and in particular psychomotor seizures. It has being marketed in Europe, including in Poland, Spain, and the United Kingdom. Pheneturide is supplied in compressed tablets each containing 200 mg. of the drug. It can also be obtained in compound tablets (" trinuride ') each of which contain 200 mg. of pheneturide, 40 mg. of diphenylhydantoin, and 15 mg. of phenobarbitone. Animal experiments have shown that pheneturide protects against drug-induced and electrically induced convulsions.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ndrugs.com/?s=laburide |
Primary | Laburide Approved UseIndications: epilepsy |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:26:50 GMT 2023
by
admin
on
Fri Dec 15 16:26:50 GMT 2023
|
Record UNII |
878CEJ4HGX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN03AX13
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
||
|
WHO-ATC |
N03AX13
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8614
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
C005825
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107062
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
100000082233
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
878CEJ4HGX
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
SUB09760MIG
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
C72826
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
2125
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
90-49-3
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
DB13362
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
PHENETURIDE
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
72060
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
6509-31-5
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
SUPERSEDED | |||
|
DTXSID4020612
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
648
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY | |||
|
201-998-2
Created by
admin on Fri Dec 15 16:26:50 GMT 2023 , Edited by admin on Fri Dec 15 16:26:50 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |